… oxaliplatin with human serum albumin (… oxaliplatin with HSA was static quenching
mechanism. The value of 1.64 nm for the distance r between the donor (HSA) and acceptor (oxaliplatin…

… (WCID) was used to investigate drug-protein interactions. This study … anticancer drug,
oxaliplatin, with human serum albumin (HSA) in aqueous solution at physiological pH with drug …

… anti-cancer agents, a carrier could be used to deliver a drug … of Pt anticancer complexes as
oxaliplatin in human plasma … In studies, the anti-cancer palladium drug, oxalipalladium, was …

… homology with human serum albumin, … serum of bovine blood [11]. BSA nanoparticles (BSANPs)
are a suitable candidate for anticancer drugs to reduce the complications of anticancer …

… is the use of human serum albumin (HSA) as a carrier. Abraxane®, 19,20 an albumin-bound …
to fully understand the impact of albumin-targeting on the biology of anticancer agents. …

… The FDA-approved platinum-based drugs cisplatin, carboplatin, and oxaliplatin are widely
… of anticancer drugs can be attributed to its nonimmunotoxicity, long circulation time in blood, …

… Cisplatin is known to have the most potent anticancer effects, as well as serious side effects
… Cisplatin, carboplatin, oxaliplatin and bovine serum albumin were purchased from Sigma-…

… of the large number of drug binding sites on the albumin molecule [5]. Interaction between
oxaliplatin as injectable anticancer drugs and human serum albumin was indicated that van …

… Albumin is the most abundant plasma protein (35–50 g L −1 in human plasma) with an average
(plasma… Oxaliplatin is one of the most efficient anticancer drugs against colorectal cancer …

… (1a), oxaliplatin (3a), and satraplatin (5a). The presence of a hexadecanoic chain allowed
binding with human serum albumin (HSA) for drug … Platinum anticancer drug candidates are …